Medicare and Medicaid
Our work in Medicare and Medicaid
-
How Can the Biden Administration Improve the Medicaid Program?
The panel will examine options to improve Medicaid eligibility rules, enrollment processes, and benefit designs, as well as approaches that could improve the quality and efficiency of the care delivered to Medicaid beneficiaries.
Categorized in -
Association Between Race/Ethnicity and Disparities in Health Care Use Before First-Episode Psychosis Among Privately Insured Young Patients
Racial/ethnic disparities in health care use and clinical outcomes for behavioral health disorders, including psychosis, are well documented, but less is known about these disparities during the period leading up to first-episode psychosis (FEP).
Categorized in -
Associations of Intensive Lifestyle Intervention in Type 2 Diabetes With Health Care Use, Spending, and Disability
Is an intensive lifestyle intervention for type 2 diabetes associated with long-term health care use and Medicare spending?
Categorized in -
Cognitive Assessment At Medicare’s Annual Wellness Visit In Fee-For-Service And Medicare Advantage Plans
The study provides new insights – the self-reports of survey respondents – into cognitive assessments at annual wellness visits, an area that has been somewhat hidden from view.
Categorized in -
Most Medicare Beneficiaries Say They Don’t Receive Structured Cognitive Assessments at Wellness Visits
The results reinforce the need to evaluate policies and practices around detecting impairment, according to the researchers.
-
Understanding The Latest ACO “Savings”: Curb Your Enthusiasm And Sharpen Your Pencils—Part 2
In this post, the authors lay out key considerations for improving the MSSP over the long haul with the objective of helping get a repeatedly derailed conversation back on track.
Categorized in -
Understanding The Latest ACO “Savings”: Curb Your Enthusiasm And Sharpen Your Pencils—Part 1
Did the MSSP save Medicare $1.2 billion in 2019? No—not even close. Might the true net savings be close to zero? Quite possibly.
Categorized in -
Sharing Drug Rebates With Medicare Part D Patients: Why And How
The percentage of total Medicare Part D drug spending offset by rebates on branded drugs increased from 11% in 2010 to 25% in 2018.
Categorized in -
The Future of Value-Based Payment
Join Schaeffer Center Associate Director Erin Trish in conversation with Elizabeth Fowler, Executive Vice President for Programs at The Commonwealth Fund, and Schaeffer Initiative Director Paul Ginsburg for a discussion of the future of value-based payment in the U.S.
Categorized in -
Improved Survival for Individuals with Common Chronic Conditions in the Medicare Population
It is well established that the United States lags behind peer nations in life expectancy, but it is less established that there is heterogeneity in life expectancy trends. We compared mortality trends from 2004 to 2014 for the United States with 17 high-income countries for persons under and over 65. The United States ranked last […]
Categorized in